|
1
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu H, Lv Z, An C, Shi M, Pan W, Zhou L,
Yang W and Yang M: Onco-lncRNA HOTAIR and its functional genetic
variants in papillary thyroid carcinoma. Sci Rep. 6:319692016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jendrzejewski J, Thomas A, Liyanarachchi
S, Eiterman A, Tomsic J, He H, Radomska HS, Li W, Nagy R, Sworczak
K and de la Chapelle A: PTCSC3 is involved in papillary thyroid
carcinoma development by modulating S100A4 gene expression. J Clin
Endocrinol Metab. 100:1370–1377. 2015. View Article : Google Scholar
|
|
4
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sørensen KP, Thomassen M, Tan Q, Bak M,
Cold S, Burton M, Larsen MJ and Kruse TA: Long non-coding RNA
HOTAIR is an independent prognostic marker of metastasis in
estrogen receptor-positive primary breast cancer. Breast Cancer Res
Treat. 142:529–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Svoboda M, Slyskova J, Schneiderova M,
Makovicky P, Bielik L, Levy M, Lipska L, Hemmelova B, Kala Z,
Protivankova M, et al: HOTAIR long non-coding RNA is a negative
prognostic factor not only in primary tumors, but also in the blood
of colorectal cancer patients. Carcinogenesis. 35:1510–1515. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang JX, Han L, Bao ZS, Wang YY, Chen LY,
Yan W, Yu SZ, Pu PY, Liu N, et al: HOTAIR, a cell cycle-associated
long noncoding RNA and a strong predictor of survival, is
preferentially expressed in classical and mesenchymal glioma. Neuro
Oncol. 15:1595–1603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu ZM, Wu ZY, Li WH, Wang LQ, Wan JN and
Zhong Y: MiR-96-5p promotes the proliferation, invasion and
metastasis of papillary thyroid carcinoma through down-regulating
CCDC67. Eur Rev Med Pharmacol Sci. 23:3421–3430. 2019.PubMed/NCBI
|
|
9
|
Zhou SL, Tang QL, Zhou SX and Ren RZ:
MiR-296-5p suppresses papillary thyroid carcinoma cell growth via
targeting PLK1. Eur Rev Med Pharmacol Sci. 23:2084–2091.
2019.PubMed/NCBI
|
|
10
|
Zhang Y, Sun B, Zhao L, Liu Z, Xu Z, Tian
Y and Hao C: Up-Regulation of miRNA-148a inhibits proliferation,
invasion, and migration while promoting apoptosis of cervical
cancer cells by down-regulating RRS1. Biosci Rep.
39:BSR201818152019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Y, Zhu Q, Zhou M, Yang W, Shi H, Shan
Y, Zhang Q and Yu F: Restoration of miRNA-148a in pancreatic cancer
reduces invasion and metastasis by inhibiting the Wnt/β-catenin
signaling pathway via downregulating maternally expressed gene-3.
Exp Ther Med. 17:639–648. 2019.PubMed/NCBI
|
|
12
|
Shi L, Xi J, Xu X, Peng B and Zhang B:
MiR-148a suppressed cell invasion and migration via targeting
WNT10b and modulating β-catenin signaling in cisplatin-resistant
colorectal cancer cells. Biomed Pharmacother. 109:902–909. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi H, Chen X, Jiang H, Wang X, Yu H, Sun
P and Sui X: MiR-148a suppresses cell invasion and migration in
gastric cancer by targeting DNA methyltransferase 1. Oncol Lett.
15:4944–4950. 2018.PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-(Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choy M, Guo Y, Li H, Wei G, Ye R, Liang W,
Xiao H, Li Y and Guan H: Long noncoding RNA LOC100129940-N is
upregulated in papillary thyroid cancer and promotes the invasion
and progression. Int J Endocrinol. 2019:70435092019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo K, Chen L, Wang Y, Qian K, Zheng X,
Sun W, Sun T, Wu Y and Wang Z: Long noncoding RNA RP11-547D24.1
regulates proliferation and migration in papillary thyroid
carcinoma: Identification and validation of a novel long noncoding
RNA through integrated analysis of TCGA database. Cancer Med.
1:3105–3119. 2019. View Article : Google Scholar
|
|
17
|
Liang M, Jia J, Chen L, Wei B, Guan Q,
Ding Z, Yu J, Pang R and He G: LncRNA MCM3AP-AS1 promotes
proliferation and invasion through regulating miR-211-5p/SPARC axis
in papillary thyroid cancer. Endocrine. 27:318–326. 2019.
View Article : Google Scholar
|
|
18
|
Song B, Li R, Zuo Z, Tan J, Liu L, Ding D,
Lu Y and Hou D: LncRNA ENST00000539653 acts as an oncogenic factor
via MAPK signalling in papillary thyroid cancer. BMC Cancer.
19:2972019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang XZ, Hang YK, Liu JB, Hou YQ, Wang N
and Wang MJ: Over-Expression of microRNA-375 inhibits papillary
thyroid carcinoma cell proliferation and induces cell apoptosis by
targeting ERBB2. J Pharmacol Sci. 130:78–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu L, Wang J, Li X, Ma J, Shi C, Zhu H,
Xi Q, Zhang J, Zhao X and Gu M: MiR-204-5p suppresses cell
proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Biochem Biophys Res Commun. 457:621–626. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H, Zhao L, Zhang Z, Zhang H, Ding C and
Su Z: Roles of microRNA let-7b in papillary thyroid carcinoma by
regulating HMGA2. Tumour Biol. 39:1010428317719274. 2017.
View Article : Google Scholar
|
|
22
|
Fang M, Huang W, Wu X, Gao Y, Ou J, Zhang
X and Li Y: MiR-141-3p suppresses tumor growth and metastasis in
papillary thyroid cancer via targeting yin yang 1. Anat Rec
(Hoboken). 302:258–268. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leone V, D'Angelo D, Rubio I, de Freitas
PM, Federico A, Colamaio M, Pallante P, Medeiros-Neto G and Fusco
A: MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting
CCND2, CXCR4, and SDF-1alpha. J Clin Endocrinol Metab.
96:E1388–E1398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han C, Zheng W, Ge M, Wang K, Xiang Y and
Wang P: Downregulation of cyclin-dependent kinase 8 by
microRNA-148a suppresses proliferation and invasiveness of
papillary thyroid carcinomas. Am J Cancer Res. 7:2081–2090.
2017.PubMed/NCBI
|
|
25
|
Xu Y, Han YF, Zhu SJ, Dong JD and Ye B:
MiRNA-148a inhibits cell growth of papillary thyroid cancer through
STAT3 and PI3K/AKT signaling pathways. Oncol Rep. 38:3085–3093.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Han J, Zhang M, Nie C, Jia J, Wang F, Yu
J, Bi W, Liu B, Sheng R, He G, et al: MiR-215 suppresses papillary
thyroid cancer proliferation, migration, and invasion through the
AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Cell Death Dis.
10:1952019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen J, Yin J, Liu J, Zhu RX, Zheng Y and
Wang XL: MiR-202-3p functions as a tumor suppressor and reduces
cell migration and invasion in papillary thyroid carcinoma. Eur Rev
Med Pharmacol Sci. 23:1145–1150. 2019.PubMed/NCBI
|
|
28
|
Xiao Y, Yan X, Yang Y and Ma X:
Downregulation of long noncoding RNA HOTAIRM1 variant 1 contributes
to osteoarthritis via regulating miR-125b/BMPR2 axis and activating
JNK/MAPK/ERK pathway. Biomed Pharmacother. 109:1569–1577. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Q, Dong C, Cui J, Wang Y and Hong X:
Over-Expressed lncRNA HOTAIRM1 promotes tumor growth and invasion
through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away
from the HOXA1 gene in glioblastoma multiforme. J Exp Clin Cancer
Res. 37:2652018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peng L, Liu Z, Xiao J, Tu Y, Wan Z, Xiong
H, Li Y and Xiao W: MicroRNA-148a suppresses epithelial-mesenchymal
transition and invasion of pancreatic cancer cells by targeting
wnt10b and inhibiting the Wnt/β-catenin signaling pathway. Oncol
Rep. 38:301–308. 2017. View Article : Google Scholar : PubMed/NCBI
|
